C/EBP PROTEINS ACTIVATE TRANSCRIPTION FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN MACROPHAGES MONOCYTES

被引:152
|
作者
HENDERSON, AJ
ZOU, X
CALAME, KL
机构
[1] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MICROBIOL,NEW YORK,NY 10032
[2] COLUMBIA UNIV,COLL PHYS & SURG,DEPT BIOCHEM,NEW YORK,NY 10032
[3] COLUMBIA UNIV,COLL PHYS & SURG,DEPT MOLEC BIOPHYS,NEW YORK,NY 10032
关键词
D O I
10.1128/JVI.69.9.5337-5344.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Three binding sites for C/EBP proteins are found in the human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR) (V. M. Tesmer, A. Rajadhyaksha, J. Babin, and M. Bina, Proc. Natl. Acad. Sci. USA 90:7298-7302, 1993). We have determined the functional role of C/EBP proteins and C/EBP sites in regulating transcription from the HIV-1 LTR in monocytes/macrophages. Inhibition of endogenous C/EBP proteins, using either an excess of C/EBP binding sites or a trans-dominant negative inhibitor, demonstrated that C/EBP proteins are required for basal and activated levels of HIV-1 LTR transcription in the promonocytic cell line U937. Northern (RNA) blots and binding assays showed that NF-IM is the only known C/EBP family member which is increased when U937 cells are activated. Mutational analyses of the HN-I LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent. However, transcription from crippled HIV-1 LTRs lacking C/EBP sites can still be induced following activation of U937 cells. Several models are suggested for how elevated NF-IM may participate in an autostimulatory loop involving HIV infection, macrophage activation, cytokine expression, and HIV replication.
引用
收藏
页码:5337 / 5344
页数:8
相关论文
共 50 条
  • [41] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN CYTOKINE-STIMULATED MONOCYTES MACROPHAGES BY COMBINATION THERAPY
    RUSCONI, S
    MERRILL, DP
    HIRSCH, MS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (06): : 1361 - 1366
  • [42] 3 INHIBITORS OF TYPE-1 HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT-DIRECTED GENE-EXPRESSION AND VIRUS-REPLICATION
    LI, CJ
    ZHANG, LJ
    DEZUBE, BJ
    CRUMPACKER, CS
    PARDEE, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1839 - 1842
  • [43] DEGRADATION OF CYTOSKELETAL PROTEINS BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE
    HONER, B
    SHOEMAN, RL
    TRAUB, P
    [J]. CELL BIOLOGY INTERNATIONAL REPORTS, 1992, 16 (07) : 603 - 612
  • [44] THE ENVELOPE GLYCOPROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 STIMULATES RELEASE OF NEUROTOXINS FROM MONOCYTES
    GIULIAN, D
    WENDT, E
    VACA, K
    NOONAN, CA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 2769 - 2773
  • [45] SEQUENCE-SPECIFIC BINDING OF THE TRANSCRIPTION FACTOR-C-ETS1 TO THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I LONG TERMINAL REPEAT
    HOLZMEISTER, J
    LUDEWIG, B
    PAULI, G
    SIMON, D
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (03) : 1229 - 1233
  • [46] EFFECTS OF THE TAT AND NEF GENE-PRODUCTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ON TRANSCRIPTION CONTROLLED BY THE HIV-1 LONG TERMINAL REPEAT AND ON CELL-GROWTH IN MACROPHAGES
    MURPHY, KM
    SWEET, MJ
    ROSS, IL
    HUME, DA
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (12) : 6956 - 6964
  • [47] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    [J]. PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [48] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [49] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [50] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IS ACTIVATED BY MONOFUNCTIONAL AND BIFUNCTIONAL DNA ALKYLATING-AGENTS IN HUMAN-LYMPHOCYTES
    QUINTO, I
    RUOCCO, MR
    BALDASSARRE, F
    MALLARDO, M
    DRAGONETTI, E
    SCALA, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (35) : 26719 - 26724